This ‘Digital meets Health’ networking session will open doors to larger brands who are looking to the digital community to implement agile innovation. The session will showcase companies developing disruptive data capture technologies, innovative data-driven applications and visualisation techniques, and new ways of sharing personal data.The event will take place 5:30-8:30pm on Wednesday 20th July in Central London. Up to 16 of the most innovative companies to apply to attend will be invited to meet with established industry brands, for an evening of facilitated networking.

 

Axa PPP Healthcare: There are stories in the press everyday about the ageing population; the lack of resources to support older people and hospital beds being “blocked” by people who are clinically discharged but unable to leave because of the lack of services to support them – be that in their own homes or in a residential setting. The private medical insurance provider is looking at innovative solutions to support both health and social care needs to enable people to live safe and happy lives with less reliance on the hospital environment.

Merck Sharp & Dohme: The healthcare organisation is interested in re-imagining healthcare through the eyes of start-ups to help look beyond pharmaceuticals to holistically improve patient care.

GlaxoSmithKline: The British pharmaceutical company are particularly interested in technologies to enable monitoring of patients outside the clinic during clinical trials.

AstraZeneca: The global biopharmaceutical company is looking to optimise outcomes for patients through the use of digital health tools working in combination with their drug product portfolio. They are particularly interested in a number of technology types including: digital systems to ensure medicines compliance, non-invasive technologies to measure patient parameters and digital systems to analyse the data that these systems generate, and systems to enable the use of patient information to efficiently deliver treatment and care.

Bupa: It is a transformative period of time for healthcare:  patients’ needs are changing as digital technology becomes more prevalent, and customer purchasing habits are becoming more geared towards ‘immediate value’.  The future of healthcare needs to be designed for everyone, taking into account diversity in needs, cultural backgrounds, motivations and behaviours. ‘One size fits all’ will not work in healthcare.  It is this increased demand that is leading Bupa to focus on the creation of person-centred digital products and services worldwide.

Johnson & Johnson: Johnson & Johnson is interested in sensors and wearables bringing a new dimension in data capture machine learning, algorithms and analytics leading to messaging & coaching about health in general. They are also looking for any clearly differentiated technology to help patients with a chronic or degenerative condition.

Eli Lilly: The main areas of interest for Eli Lilly are based on making patient consent easier to obtain ahead of clinical trials. This will speed up and enhance patient recruitment using digital tools linked to, for example, new websites, web screeners and digital marketing campaigns. Visit scheduling during clinical trials is also important to Lilly as are Innovative ways to connect with patients during and after the trials. Tools to achieve this could include new blogging systems, the innovative use of twitter channels for clinical innovation and the development of rich content for these new systems.

Event format

The event format has been designed to connect entrepreneurs with potential clients and collaborators through a series of rapid ‘speed dating’ style sessions, which may lead on to successful commercial relationships. Digital innovator attendees will rotate around the room with strictly five minutes within which to have a one-to-one conversation or pitch to each industry representative. There will be refreshments throughout the evening.